|
KIAA1467 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.63982194279333E-12 |
| Normal-vs-Stage2 |
8.89519569113872E-11 |
| Normal-vs-Stage3 |
2.29340002544376E-09 |
| Normal-vs-Stage4 |
9.7570999999963E-05 |
| Stage1-vs-Stage2 |
4.324600E-01 |
| Stage1-vs-Stage3 |
4.603800E-02 |
| Stage1-vs-Stage4 |
3.084600E-01 |
| Stage2-vs-Stage3 |
3.130200E-01 |
| Stage2-vs-Stage4 |
4.972600E-01 |
| Stage3-vs-Stage4 |
9.013200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.76365605347928E-14 |
| Normal-vs-Asian |
4.935300E-03 |
| Caucasian-vs-AfricanAmerican |
5.120000E-01 |
| Caucasian-vs-Asian |
2.187200E-01 |
| AfricanAmerican-vs-Asian |
2.374800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
5.30675503540579E-12 |
| Male-vs-Female |
2.487900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.84736728323787E-12 |
| Normal-vs-Extreme_Weight |
2.24964491479795E-12 |
| Normal-vs-Obese |
5.6976645623763E-13 |
| Normal-vs-Extreme_Obese |
1.09400000003479E-06 |
| Normal_Weight-vs-Extreme_Weight |
7.284800E-01 |
| Normal_Weight-vs-Obese |
1.849360E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.959000E-01 |
| Extreme_Weight-vs-Obese |
1.238780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.901600E-01 |
| Obese-vs-Extreme_Obese |
3.523000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.842019999998E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.71056527118208E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.193800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.214100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.142800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.587200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.721600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.748590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.33669741941844E-11 |
| Normal-VS-Type2 PRCC |
3.96271904179457E-12 |
| Normal-VS-KIRP CIMP |
1.342980E-03 |
| Normal-VS-Unclassified PRCC |
2.66160000039761E-07 |
| Type1 PRCC-VS-Type2 PRCC |
8.074400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.162500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.180100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.964200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.180100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.951600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.54718509909935E-12 |
| Normal-vs-N1 |
2.93160000053305E-07 |
| Normal-vs-N2 |
4.099700E-02 |
| N0-vs-N1 |
7.223500E-02 |
| N0-vs-N2 |
1.042430E-01 |
| N1-vs-N2 |
5.627000E-01 |
|
|
